Delta Sleep-Inducing Peptide (DSIP) is an amphiphilic nonapeptide of molecular weight 849 daltons, originally identified in experimental investigations of endogenous neuropeptides associated with sleep-related electrophysiological activity. It has been detected in both free and bound forms in the hypothalamus, limbic system, pituitary, and various peripheral cellular structures and biological fluids. In laboratory research environments, DSIP is examined as a biochemical probe for studying neuropeptide-mediated regulation of neuronal excitability and network-level coordination. Experimental literature describes DSIP as interacting with multiple neurochemical systems, including opioid-associated receptors, GABAergic signaling pathways, and monoaminergic neurotransmitter systems. These pathways are typically investigated using receptor-binding assays, electrophysiological recordings, and neurochemical release measurements. Additional experimental work has examined DSIP-associated changes in hypothalamic–pituitary–adrenal (HPA) axis markers, autonomic nervous system activity, and oxidative stress response signaling. Reported observations vary across experimental models and should be interpreted within each study’s specific conditions. Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu Molecular Formula: C₃₅H₄₈N₁₀O₁₅ Molecular Weight: 848.82 g/mol Supplied exclusively for non-clinical laboratory research. Not for human consumption.